Precisely Extends Data Integrity Leadership with New Innovations in First-of-its-Kind Data Integrity Suite
Precisely, the global leader in data integrity, today launched its new Precisely Data Integrity Suite – bringing the latest innovation in data integrity to the market. Announced at the company’s Trust ’22 event, the Data Integrity Suite is composed of seven interoperable SaaS modules that can be deployed individually, or seamlessly combined to deliver exponential value – fuelling businesses with unparalleled levels of trusted data.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220621005275/en/
The Precisely Data Integrity Suite is composed of seven interoperable SaaS modules that can be deployed individually, or seamlessly combined to deliver exponential value - fuelling businesses with unparalleled levels of trusted data. (Graphic: Business Wire)
The announcement comes at the same time as the latest IDC Spotlight paper on “Improving Data Integrity and Trust through Transparency and Enrichment,” shows that only 27% of data professionals say they completely trust their data. With 63% of organizations reporting that higher levels of data integrity make a positive impact on their business metrics 1, the launch of the new Data Integrity Suite is a timely one.
“Data integrity is an imperative for every business, but the journey to achieving it is different for every organization. With the Precisely Data Integrity Suite, businesses can start anywhere, go at their own pace, and grow value at every step of their unique journey,” said Eric Yau, COO at Precisely. “Our unmatched breadth of data integrity capabilities and enrichment data, combined with our strategic services expertise, means that we can help businesses chart their path to data integrity and lead them along the way.”
The Suite’s Data Integration, Data Observability, and Data Governance modules are available for early access now for businesses looking to build a foundation of accuracy and consistency in their data:
-
Data Integration
: enables organizations to break down silos by quickly building streaming data pipelines that integrate data from core transaction systems into modern data platforms, driving innovation, and modernizing mission-critical infrastructure
-
Data Observability
: a new entry from Precisely into this rapidly growing market, proactively and intelligently detects and surfaces data anomalies before they become costly downstream issues that could disrupt business
- Data Governance: delivers a business-friendly framework to find, understand, trust, and leverage critical data across an organization for better outcomes and insights, improved operations, and regulatory compliance
The following modules will join the Data Integrity Suite in the coming months:
-
Data Quality: delivers data that is accurate, consistent, complete, and fit for purpose across operational and analytical systems
-
Geo Addressing: unlocks valuable context by verifying, standardizing, cleansing, and geocoding addresses for more informed decision-making
-
Spatial Analytics: derives and visualizes spatial relationships hidden in data to reveal critical context for better decisions
- Data Enrichment: enriches data with expertly curated datasets containing thousands of attributes for faster, more confident decisions
The Data Integrity Suite delivers access to trusted data at the speed of business and empowers organizations to make fast, confident decisions that drive growth, reduce costs, and manage risk. With a business-friendly user experience, it supports data democratization and self-service access to data for business and data users alike. Its unique Data Integrity Foundation includes a common data catalog that enables each module to build on metadata previously gathered by other modules, combining seamlessly to deliver maximum value to the customer.
“With the launch, Precisely is delivering on the vision they have painted for the market of integrating its capabilities into a modular, interoperable suite,” said Stewart Bond, Research Director at IDC. “Precisely has a strategic blend of technology and services within its portfolio to meet the needs of organizations with legacy and modern data environments that are wanting to compete in a digital-first world.”
“Businesses are increasingly investing in DataOps to continually improve the data they use for analytics and decision-making. The Precisely Data Integrity Suite’s end-to-end, integrated approach to data integration, data governance and quality, as well as location intelligence and data enrichment gives organizations all the tools and agility they need to automate and iterate on the integrity of their data,” said Anjan Kundavaram, CPO at Precisely. “The introduction of the Suite’s Data Observability module is essential for DataOps teams, allowing them to leverage AI and machine learning to gain critical insight into the health of their company’s data, monitor changes to patterns in that data, and proactively resolve potential issues.”
Financial services company, Degroof Petercam, a Precisely customer and participant in the Data Integrity Suite’s early access program, sees clear benefits of the new Data Observability module. “Observability is the missing piece today to give our data stewards access to data discovery insights without having to go to IT for queries or reports.” explains Jean-Paul Otte, Chief Data Officer at Degroof Petercam.
“The portfolio of data integrity assets that Precisely offers is the gold standard for building trusted data,” said Yau. “That same technology, recognized by industry analysts and relied upon by over 12,000 customers to address their data challenges today, is at the heart of the new Precisely Data Integrity Suite – providing the ultimate modular, interoperable, solution for organizations relying on data integrity across both legacy and modern cloud environments.”
Learn more about the new Data Integrity Suite and watch the 90-second video.
Data Integrity Suite Video Embed: <iframe width="560" height="315" src="https://www.youtube.com/embed/0y-YZDoeutc" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
- IDC Spotlight, sponsored by Precisely, “Improving Data Integrity and Trust Through Transparency and Enrichment” (doc # US49285622, June 2022)
About Precisely
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in data for 12,000 customers in more than 100 countries, including 99 of the Fortune 100. Precisely’s data integration, data quality, data governance, location intelligence, and data enrichment products power better business decisions to create better outcomes. Learn more at www.precisely.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220621005275/en/
Contact information
Press Contact
Ned Tadic (US)
Emma Forrest (Europe)
press@precisely.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 01:49:00 EET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
